Drug Eluting Balloon Catheter Market

Drug Eluting Balloon Catheter Market Analysis by Indication (Coronary Artery Disease Drug Eluting Balloon Catheters, Peripheral Vascular Disease Drug Eluting Balloon Catheters), by End User (Hospitals, Ambulatory Surgical Centers), by Raw Material & Regional Forecast, 2021 to 2031

Analysis of Drug Eluting Balloon Catheter market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Drug Eluting Balloon Catheter Market Outlook

The global market for drug eluting balloon catheters is anticipated to progress at an impressive CAGR of 18% over the next ten years. This analysis has been performed by skilled analysts at Fact.MR, a market research and competitive intelligence provider, also reveals that demand for drug eluting balloon catheters comprises 20% share in the overall balloon catheters market at present.

Report Attributes Details
Global Market Value in 2021 US$ 1 Bn
CAGR (2021 to 2031) 18%
Forecasted Market Value for 2031 US$ 5.2 Bn
Dominant Market Europe

As per the study, the global drug eluting balloon catheter market is expected to be worth US$ 5.2 Bn by the end of 2031, with coronary artery disease drug eluting balloon catherization holding a mammoth 80% market share.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Drug Eluting Balloon Catheter Demand Analysis (2016 to 2020) Vs Future Market Projections (2021 to 2031)

Healthcare infrastructure has seem some major changes over the past decade as technology proliferation increased and research on healthcare has also seen a substantial boom. Rising obesity, increasing geriatric population, and growing prevalence of coronary artery diseases are some of the factors propelling demand for drug eluting balloon catheters. When stents are used with a balloon catheter it is called a balloon expandable stent, which differs from self-expandable stents, and these are normally made from nitinol alloy.

Adoption of angioplasty balloons for patients who do not benefit from percutaneous coronary intervention (PCI) is also favouring growth of the drug eluting balloon (DEB) catheter market. Increased support from governments and other institutions backing research and granting funding to further develop drug eluting balloon catheters is being witnessed.

Overall demand is anticipated to rise at a stellar CAGR of around 18% over the decade.

What is the Outlook for the Peripheral Vascular Disease DEB Catheter Market?

Usage of drug eluting devices is majorly associated with cardiac conditions, and these are used to reduce the rate of restenosis. The peripheral drug-coated balloon catheter market is poised to rise at a steady CAGR over the next ten years. Use of drug-eluting balloon catheters for peripheral artery procedures is anticipated to increase as their benefits are realized and procedures become more affordable.

Under the indication segment, demand for coronary artery disease drug eluting balloon catheters is anticipated to account for nearly 80% market share in terms of value. Despite minimal market share, demand for peripheral vascular disease drug-eluting balloon catheters is anticipated to rise at a steady CAGR over the forecast period.

As more angioplasty balloons are being researched and developed, it is estimated that sales of peripheral drug-coated balloon catheters will also see an upward trend.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

What is the Regional Outlook of the Drug Eluting Balloon Catheter Market?

This research details the global drug eluting balloon catheter industry landscape across the regions of North America, Latin America, Europe, APAC, and MEA.

Europe dominates the market and is anticipated to continue its domination throughout the forecast period. The U.K. is anticipated to lead the European market, surging at a stellar CAGR of around 20%.

North America is anticipated to be the second-largest market. The market in Asia is anticipated to rise at the fastest CAGR through the forecast period. India and China are anticipated to lead demand in the APAC region.

Adoption of drug eluting balloon catheters in MEA is expected to pick up pace as healthcare infrastructure develops across the region.

Country-wise Analysis

What Scope Does the U.S. Drug Eluting Balloon Catheter Market Provide?

The U.S. represents the largest market for drug eluting balloons in North America, followed by Canada. The nation has been seeing a surge in cardiac cases due to rising prevalence of obesity, poor lifestyle choices, rise in aging population, presence of key players, and high spending potential. This is propelling sales of drug-coated balloon (DCB) catheters in the U.S.

Will China Be a Profitable Market for Drug Eluting Balloon Catheter Suppliers?

China has a massive population and the geriatric population in the nation is on the rise, which, in turn, is increasing instances of cardiovascular diseases and disorders. Government-backed research initiatives are helping reshape and bolster the healthcare infrastructure in the nation. Rising medical tourism, high prevalence of cardiovascular diseases, and rapidly developing healthcare infrastructure are some of the factors driving demand in China.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Category-wise Analysis

How is Demand for Polyurethane Drug Eluting Balloon Catheters Expected to Play Out?

Sales of polyurethane drug eluting balloon catheters are expected to rise at the fastest CAGR as far as raw material is concerned. However, demand for nylon drug eluting balloon catheters is expected to account for a majority of share among all. Benefits such as soft nature, foldability, and easy withdrawal are propelling sales of nylon drug eluting balloon catheters.

Competitive Landscape

Research in the drug eluting balloon catheter space by key players is anticipated bolster development and sales of more precise and efficient drug eluting balloon catheters.

  • In February 2021, L2Mtech GmbH was awarded its first CE mark on six products. This marks a milestone in the company’s history and proves the efficacy and safety of its innovative cardiovascular and endovascular applications. The company is planning to commercially launch the products with the CE mark recognition.
  • In June 2020, iVascular SLU, a medical device company, announced the global launch of its novel coronary artery drug-coated balloon. The product - Essential Pro - has several improvements from its predecessor.
  • In March 2021, MedAlliance announced that it had received FDA approval for its drug-eluting coronary balloon. The product is called the Selution SLR sustained limus release drug-eluting balloon catheter. It received a go-ahead for its design, which improved luminal diameter in individuals affected with atherosclerotic lesions.

Drug Eluting Balloon Catheter Industry Report Scope

Report Attributes Details
Forecast Period 2021 to 2031
Historical Data Available for 2016 to 2020
Market Analysis Units for Sales US$ Mn for Value
Key Regions Covered North America; Latin America; Europe; APEJ; MEA
Key Countries Covered United States, Canada, Brazil, Mexico, Germany, U.K., France, Spain, Italy, China, Japan, South Korea, India, Indonesia, Malaysia, Singapore, Australia, New Zealand, Turkey, South Africa, and GCC Countries
Key Market Segments Covered Indication, End User, Raw Material, Region
Key Companies Profiled Cardionovum GmbH; Cook Medical INC; Cordis Corporation; Abbott Laboratories; Meril Life Sciences Pvt Ltd; Jotech GmbH; MicroPort Scientific Corporation; Terumo Corporation; Boston Scientific Corporation
Pricing Available upon Request

MaKey Segments of Drug Eluting Balloon Catheter Industry Surveyrket Taxonomy

  • By Indication:

    • Coronary Artery Disease Drug Eluting Balloon Catheters
    • Peripheral Vascular Disease Drug Eluting Balloon Catheters
  • By End User:

    • Hospitals
    • Ambulatory Surgical Centers
    • Cardiac Catheterization Laboratories
  • By Raw Material:

    • Polyurethane Drug Eluting Balloon Catheters
    • Nylon Drug Eluting Balloon Catheters
    • Others

Table of Content

  • 1. Global Market - Executive Summary
  • 2. Global Market Overview
  • 3. Global Market Analysis and Forecast By Indication
    • 3.1. Coronary Artery Disease
    • 3.2. Peripheral Vascular Disease
  • 4. Global Market Analysis and Forecast By End User
    • 4.1. Hospitals
    • 4.2. Ambulatory Surgical Centers
    • 4.3. Cardiac Catheterization Laboratories
  • 5. Global Market Analysis and Forecast By Raw Material
    • 5.1. Polyurethane
    • 5.2. Nylon
    • 5.3. Others
  • 6. Global Market Analysis and Forecast By Region
    • 6.1. North America
    • 6.2. Latin America
    • 6.3. Europe
    • 6.4. Japan
    • 6.5. APEJ
    • 6.6. MEA
  • 7. North America Market Analysis and Forecast, By Country, 2016 to 2031
  • 8. Latin America Market Analysis and Forecast, By Country, 2016 to 2031
  • 9. Europe Market Analysis and Forecast, By Country, 2016 to 2031
  • 10. Japan Market Analysis and Forecast, By Country, 2016 to 2031
  • 11. APEJ Market Analysis and Forecast, By Country, 2016 to 2031
  • 12. MEA Market Analysis and Forecast, By Country, 2016 to 2031
  • 13. Global Market Company/Manufacturers/Distributors/Suppliers Profile and Revenue Projections
    • 13.1. Boston Scientific Inc.
    • 13.2. Medtronic
    • 13.3. Terumo Corporation
    • 13.4. MicroPort Scientific Corporation
    • 13.5. B. Braun Melsungen AG
    • 13.6. Jotech GmbH
    • 13.7. QX Medical LLC
    • 13.8. Meril Life Pvt. Ltd.
    • 13.9. Hexacath
    • 13.10. Abbott Laboratories
    • 13.11. Tokai Medical Products Inc.
    • 13.12. Biosensors International Ltd.
    • 13.13. Cook Medical Inc.
    • 13.14. Cardionovum GmbH
    • 13.15. Cordis Corporation
    • 13.16. Biotronik
  • 14. Research Methodology
  • 15. Secondary and Primary Sources
  • 16. Assumptions and Acronyms
  • 17. Disclaimer

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

TABLE 1 Global Market Value (US$ Mn), 2016 to 2020

TABLE 2 Global Market Value (US$ Mn), 2021 to 2031

TABLE 3 Global Market Value (US$ Mn) and Y-o-Y, 2015 to 2031

TABLE 4 Global Coronary Artery Disease Segment Value (US$ Mn), By Region 2016 to 2020

TABLE 5 Global Coronary Artery Disease Segment Value (US$ Mn), By Region 2021 to 2031

TABLE 6 Global Coronary Artery Disease Segment Market Share, By Region 2016 to 2020

TABLE 7 Global Coronary Artery Disease Segment Market Share, By Region 2021 to 2031

TABLE 8 Global Coronary Artery Disease Segment Y-o-Y, By Region 2015 to 2031

TABLE 9 Global Peripheral Vascular Disease Segment Value (US$ Mn), By Region 2016 to 2020

TABLE 10 Global Peripheral Vascular Disease Segment Value (US$ Mn), By Region 2021 to 2031

TABLE 11 Global Peripheral Vascular Disease Segment Market Share, By Region 2016 to 2020

TABLE 12 Global Peripheral Vascular Disease Segment Market Share, By Region 2021 to 2031

TABLE 13 Global Peripheral Vascular Disease Segment Y-o-Y, By Region 2015 to 2031

TABLE 14 Global Hospitals Segment Value (US$ Mn), By Region 2016 to 2020

TABLE 15 Global Hospitals Segment Value (US$ Mn), By Region 2021 to 2031

TABLE 16 Global Hospitals Segment Market Share, By Region 2016 to 2020

TABLE 17 Global Hospitals Segment Market Share, By Region 2021 to 2031

TABLE 18 Global Hospitals Segment Y-o-Y, By Region 2015 to 2031

TABLE 19 Global Ambulatory Surgical Centers Segment Value (US$ Mn), By Region 2016 to 2020

TABLE 20 Global Ambulatory Surgical Centers Segment Value (US$ Mn), By Region 2021 to 2031

TABLE 21 Global Ambulatory Surgical Centers Segment Market Share, By Region 2016 to 2020

TABLE 22 Global Ambulatory Surgical Centers Segment Market Share, By Region 2021 to 2031

TABLE 23 Global Ambulatory Surgical Centers Segment Y-o-Y, By Region 2015 to 2031

TABLE 24 Global Cardiac Catheterization Laboratories Segment Value (US$ Mn), By Region 2016 to 2020

TABLE 25 Global Cardiac Catheterization Laboratories Segment Value (US$ Mn), By Region 2021 to 2031

TABLE 26 Global Cardiac Catheterization Laboratories Segment Market Share, By Region 2016 to 2020

TABLE 27 Global Cardiac Catheterization Laboratories Segment Market Share, By Region 2021 to 2031

TABLE 28 Global Cardiac Catheterization Laboratories Segment Y-o-Y, By Region 2015 to 2031

TABLE 29 Global Polyurethane Segment Value (US$ Mn), By Region 2016 to 2020

TABLE 30 Global Polyurethane Segment Value (US$ Mn), By Region 2021 to 2031

TABLE 31 Global Polyurethane Segment Market Share, By Region 2016 to 2020

TABLE 32 Global Polyurethane Segment Market Share, By Region 2021 to 2031

TABLE 33 Global Polyurethane Segment Y-o-Y, By Region 2015 to 2031

TABLE 34 Global Nylon Segment Value (US$ Mn), By Region 2016 to 2020

TABLE 35 Global Nylon Segment Value (US$ Mn), By Region 2021 to 2031

TABLE 36 Global Nylon Segment Market Share, By Region 2016 to 2020

TABLE 37 Global Nylon Segment Market Share, By Region 2021 to 2031

TABLE 38 Global Nylon Segment Y-o-Y, By Region 2015 to 2031

TABLE 39 Global Others Segment Value (US$ Mn), By Region 2016 to 2020

TABLE 40 Global Others Segment Value (US$ Mn), By Region 2021 to 2031

TABLE 41 Global Others Segment Market Share, By Region 2016 to 2020

TABLE 42 Global Others Segment Market Share, By Region 2021 to 2031

TABLE 43 Global Others Segment Y-o-Y, By Region 2015 to 2031

TABLE 44 North America Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 45 North America Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 46 North America Market Value (US$ Mn), By End User 2016 to 2020

TABLE 47 North America Market Value (US$ Mn), By End User 2021 to 2031

TABLE 48 North America Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 49 North America Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 50 Latin America Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 51 Latin America Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 52 Latin America Market Value (US$ Mn), By End User 2016 to 2020

TABLE 53 Latin America Market Value (US$ Mn), By End User 2021 to 2031

TABLE 54 Latin America Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 55 Latin America Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 56 Europe Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 57 Europe Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 58 Europe Market Value (US$ Mn), By End User 2016 to 2020

TABLE 59 Europe Market Value (US$ Mn), By End User 2021 to 2031

TABLE 60 Europe Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 61 Europe Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 62 Japan Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 63 Japan Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 64 Japan Market Value (US$ Mn), By End User 2016 to 2020

TABLE 65 Japan Market Value (US$ Mn), By End User 2021 to 2031

TABLE 66 Japan Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 67 Japan Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 68 APEJ Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 69 APEJ Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 70 APEJ Market Value (US$ Mn), By End User 2016 to 2020

TABLE 71 APEJ Market Value (US$ Mn), By End User 2021 to 2031

TABLE 72 APEJ Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 73 APEJ Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 74 MEA Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 75 MEA Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 76 MEA Market Value (US$ Mn), By End User 2016 to 2020

TABLE 77 MEA Market Value (US$ Mn), By End User 2021 to 2031

TABLE 78 MEA Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 79 MEA Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 80 US Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 81 US Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 82 US Market Value (US$ Mn), By End User 2016 to 2020

TABLE 83 US Market Value (US$ Mn), By End User 2021 to 2031

TABLE 84 US Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 85 US Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 86 Canada Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 87 Canada Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 88 Canada Market Value (US$ Mn), By End User 2016 to 2020

TABLE 89 Canada Market Value (US$ Mn), By End User 2021 to 2031

TABLE 90 Canada Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 91 Canada Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 92 Brazil Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 93 Brazil Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 94 Brazil Market Value (US$ Mn), By End User 2016 to 2020

TABLE 95 Brazil Market Value (US$ Mn), By End User 2021 to 2031

TABLE 96 Brazil Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 97 Brazil Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 98 Mexico Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 99 Mexico Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 100 Mexico Market Value (US$ Mn), By End User 2016 to 2020

TABLE 101 Mexico Market Value (US$ Mn), By End User 2021 to 2031

TABLE 102 Mexico Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 103 Mexico Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 104 Argentina Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 105 Argentina Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 106 Argentina Market Value (US$ Mn), By End User 2016 to 2020

TABLE 107 Argentina Market Value (US$ Mn), By End User 2021 to 2031

TABLE 108 Argentina Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 109 Argentina Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 110 UK Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 111 UK Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 112 UK Market Value (US$ Mn), By End User 2016 to 2020

TABLE 113 UK Market Value (US$ Mn), By End User 2021 to 2031

TABLE 114 UK Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 115 UK Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 116 Germany Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 117 Germany Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 118 Germany Market Value (US$ Mn), By End User 2016 to 2020

TABLE 119 Germany Market Value (US$ Mn), By End User 2021 to 2031

TABLE 120 Germany Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 121 Germany Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 122 France Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 123 France Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 124 France Market Value (US$ Mn), By End User 2016 to 2020

TABLE 125 France Market Value (US$ Mn), By End User 2021 to 2031

TABLE 126 France Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 127 France Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 128 Spain Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 129 Spain Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 130 Spain Market Value (US$ Mn), By End User 2016 to 2020

TABLE 131 Spain Market Value (US$ Mn), By End User 2021 to 2031

TABLE 132 Spain Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 133 Spain Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 134 Italy Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 135 Italy Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 136 Italy Market Value (US$ Mn), By End User 2016 to 2020

TABLE 137 Italy Market Value (US$ Mn), By End User 2021 to 2031

TABLE 138 Italy Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 139 Italy Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 140 Nordic Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 141 Nordic Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 142 Nordic Market Value (US$ Mn), By End User 2016 to 2020

TABLE 143 Nordic Market Value (US$ Mn), By End User 2021 to 2031

TABLE 144 Nordic Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 145 Nordic Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 146 Japan Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 147 Japan Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 148 Japan Market Value (US$ Mn), By End User 2016 to 2020

TABLE 149 Japan Market Value (US$ Mn), By End User 2021 to 2031

TABLE 150 Japan Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 151 Japan Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 152 China Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 153 China Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 154 China Market Value (US$ Mn), By End User 2016 to 2020

TABLE 155 China Market Value (US$ Mn), By End User 2021 to 2031

TABLE 156 China Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 157 China Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 158 India Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 159 India Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 160 India Market Value (US$ Mn), By End User 2016 to 2020

TABLE 161 India Market Value (US$ Mn), By End User 2021 to 2031

TABLE 162 India Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 163 India Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 164 Malaysia Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 165 Malaysia Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 166 Malaysia Market Value (US$ Mn), By End User 2016 to 2020

TABLE 167 Malaysia Market Value (US$ Mn), By End User 2021 to 2031

TABLE 168 Malaysia Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 169 Malaysia Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 170 Thailand Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 171 Thailand Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 172 Thailand Market Value (US$ Mn), By End User 2016 to 2020

TABLE 173 Thailand Market Value (US$ Mn), By End User 2021 to 2031

TABLE 174 Thailand Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 175 Thailand Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 176 Singapore Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 177 Singapore Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 178 Singapore Market Value (US$ Mn), By End User 2016 to 2020

TABLE 179 Singapore Market Value (US$ Mn), By End User 2021 to 2031

TABLE 180 Singapore Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 181 Singapore Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 182 Australia Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 183 Australia Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 184 Australia Market Value (US$ Mn), By End User 2016 to 2020

TABLE 185 Australia Market Value (US$ Mn), By End User 2021 to 2031

TABLE 186 Australia Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 187 Australia Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 188 GCC Countries Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 189 GCC Countries Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 190 GCC Countries Market Value (US$ Mn), By End User 2016 to 2020

TABLE 191 GCC Countries Market Value (US$ Mn), By End User 2021 to 2031

TABLE 192 GCC Countries Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 193 GCC Countries Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 194 South Africa Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 195 South Africa Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 196 South Africa Market Value (US$ Mn), By End User 2016 to 2020

TABLE 197 South Africa Market Value (US$ Mn), By End User 2021 to 2031

TABLE 198 South Africa Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 199 South Africa Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 200 Nigeria Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 201 Nigeria Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 202 Nigeria Market Value (US$ Mn), By End User 2016 to 2020

TABLE 203 Nigeria Market Value (US$ Mn), By End User 2021 to 2031

TABLE 204 Nigeria Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 205 Nigeria Market Value (US$ Mn), By Raw Material 2021 to 2031

TABLE 206 Israel Market Value (US$ Mn), By Indication 2016 to 2020

TABLE 207 Israel Market Value (US$ Mn), By Indication 2021 to 2031

TABLE 208 Israel Market Value (US$ Mn), By End User 2016 to 2020

TABLE 209 Israel Market Value (US$ Mn), By End User 2021 to 2031

TABLE 210 Israel Market Value (US$ Mn), By Raw Material 2016 to 2020

TABLE 211 Israel Market Value (US$ Mn), By Raw Material 2021 to 2031

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

FIG. 1 Global Market Value (US$ Mn), 2016 to 2020

FIG. 2 Global Market Value (US$ Mn) Forecast, 2021 to 2031

FIG. 3 Global Market Value (US$ Mn) and Y-o-Y, 2015 to 2031

FIG. 4 Global Coronary Artery Disease Segment Market Value (US$ Mn) By Region, 2016 to 2020

FIG. 5 Global Coronary Artery Disease Segment Market Value (US$ Mn) By Region, 2021 to 2031

FIG. 6 Global Coronary Artery Disease Segment Y-o-Y Growth Rate, By Region, 2015 to 2031

FIG. 7 Global Peripheral Vascular Disease Segment Market Value (US$ Mn) By Region, 2016 to 2020

FIG. 8 Global Peripheral Vascular Disease Segment Market Value (US$ Mn) By Region, 2021 to 2031

FIG. 9 Global Peripheral Vascular Disease Segment Y-o-Y Growth Rate, By Region, 2015 to 2031

FIG. 10 Global Hospitals Segment Market Value (US$ Mn) By Region, 2016 to 2020

FIG. 11 Global Hospitals Segment Market Value (US$ Mn) By Region, 2021 to 2031

FIG. 12 Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2015 to 2031

FIG. 13 Global Ambulatory Surgical Centers Segment Market Value (US$ Mn) By Region, 2016 to 2020

FIG. 14 Global Ambulatory Surgical Centers Segment Market Value (US$ Mn) By Region, 2021 to 2031

FIG. 15 Global Ambulatory Surgical Centers Segment Y-o-Y Growth Rate, By Region, 2015 to 2031

FIG. 16 Global Cardiac Catheterization Laboratories Segment Market Value (US$ Mn) By Region, 2016 to 2020

FIG. 17 Global Cardiac Catheterization Laboratories Segment Market Value (US$ Mn) By Region, 2021 to 2031

FIG. 18 Global Cardiac Catheterization Laboratories Segment Y-o-Y Growth Rate, By Region, 2015 to 2031

FIG. 19 Global Polyurethane Segment Market Value (US$ Mn) By Region, 2016 to 2020

FIG. 20 Global Polyurethane Segment Market Value (US$ Mn) By Region, 2021 to 2031

FIG. 21 Global Polyurethane Segment Y-o-Y Growth Rate, By Region, 2015 to 2031

FIG. 22 Global Nylon Segment Market Value (US$ Mn) By Region, 2016 to 2020

FIG. 23 Global Nylon Segment Market Value (US$ Mn) By Region, 2021 to 2031

FIG. 24 Global Nylon Segment Y-o-Y Growth Rate, By Region, 2015 to 2031

FIG. 25 Global Others Segment Market Value (US$ Mn) By Region, 2016 to 2020

FIG. 26 Global Others Segment Market Value (US$ Mn) By Region, 2021 to 2031

FIG. 27 Global Others Segment Y-o-Y Growth Rate, By Region, 2015 to 2031

FIG. 28 North America Market Value (US$ Mn), By Indication 2016 to 2020

FIG. 29 North America Market Value (US$ Mn), By Indication 2021 to 2031

FIG. 30 North America Market Value (US$ Mn), By End User 2016 to 2020

FIG. 31 North America Market Value (US$ Mn), By End User 2021 to 2031

FIG. 32 North America Market Value (US$ Mn), By Raw Material 2016 to 2020

FIG. 33 North America Market Value (US$ Mn), By Raw Material 2021 to 2031

FIG. 34 Latin America Market Value (US$ Mn), By Indication 2016 to 2020

FIG. 35 Latin America Market Value (US$ Mn), By Indication 2021 to 2031

FIG. 36 Latin America Market Value (US$ Mn), By End User 2016 to 2020

FIG. 37 Latin America Market Value (US$ Mn), By End User 2021 to 2031

FIG. 38 Latin America Market Value (US$ Mn), By Raw Material 2016 to 2020

FIG. 39 Latin America Market Value (US$ Mn), By Raw Material 2021 to 2031

FIG. 40 Europe Market Value (US$ Mn), By Indication 2016 to 2020

FIG. 41 Europe Market Value (US$ Mn), By Indication 2021 to 2031

FIG. 42 Europe Market Value (US$ Mn), By End User 2016 to 2020

FIG. 43 Europe Market Value (US$ Mn), By End User 2021 to 2031

FIG. 44 Europe Market Value (US$ Mn), By Raw Material 2016 to 2020

FIG. 45 Europe Market Value (US$ Mn), By Raw Material 2021 to 2031

FIG. 46 Japan Market Value (US$ Mn), By Indication 2016 to 2020

FIG. 47 Japan Market Value (US$ Mn), By Indication 2021 to 2031

FIG. 48 Japan Market Value (US$ Mn), By End User 2016 to 2020

FIG. 49 Japan Market Value (US$ Mn), By End User 2021 to 2031

FIG. 50 Japan Market Value (US$ Mn), By Raw Material 2016 to 2020

FIG. 51 Japan Market Value (US$ Mn), By Raw Material 2021 to 2031

FIG. 52 APEJ Market Value (US$ Mn), By Indication 2016 to 2020

FIG. 53 APEJ Market Value (US$ Mn), By Indication 2021 to 2031

FIG. 54 APEJ Market Value (US$ Mn), By End User 2016 to 2020

FIG. 55 APEJ Market Value (US$ Mn), By End User 2021 to 2031

FIG. 56 APEJ Market Value (US$ Mn), By Raw Material 2016 to 2020

FIG. 57 APEJ Market Value (US$ Mn), By Raw Material 2021 to 2031

FIG. 58 MEA Market Value (US$ Mn), By Indication 2016 to 2020

FIG. 59 MEA Market Value (US$ Mn), By Indication 2021 to 2031

FIG. 60 MEA Market Value (US$ Mn), By End User 2016 to 2020

FIG. 61 MEA Market Value (US$ Mn), By End User 2021 to 2031

FIG. 62 MEA Market Value (US$ Mn), By Raw Material 2016 to 2020

FIG. 63 MEA Market Value (US$ Mn), By Raw Material 2021 to 2031

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

Where does the market for drug eluting balloon catheters stand in terms of valuation?

In 2021, the global drug eluting balloon catheter market is expected to be worth US$ 1 Bn.

Which factors are expected to drive growth of the global drug eluting balloon catheter market?

Increasing geriatric population, rising healthcare expenditure, government initiatives backing research, and increasing proliferation of technology are some of the factors that are expected to influence demand growth.

Which indication product accounts majority market share?

Coronary artery disease drug eluting balloon catheters are expected to account for nearly 80% market share in terms of value.

What market estimates are predicted for the year 2031?

By 2031, the global market is predicted to surge to a valuation of US$ 5.2 Bn.

What is the outlook for drug eluting balloon catheter suppliers in Europe?

Europe dominates the global market in terms of share and is expected to continue its domination over the decade.

What CAGR is predicted for the market by this analysis?

Analysts have predicted the drug eluting balloon catheter industry to surge at a stellar CAGR of 18% over the decade.

Which drug eluting balloon catheter manufacturers are operating in the industry?

Top market players are Cardionovum GmbH Coo, Medical INC, Cordis Corporation, Abbott Laboratories, Meril Life Sciences Pvt Ltd, Jotech GmbH, MicroPort Scientific Corporation, Terumo Corporation, Boston Scientific Corporation, Tokai Medical Products Inc

Drug Eluting Balloon Catheter Market

Schedule a Call